Neuroimmunology - the Past, Present, and Future

Dear Colleagues,

Neuroimmunology as a separate discipline has its roots in the fields of neurology, neuroscience and immunology. While neuroimmunologists originally focused on classical neuroinflammatory disorders, such as multiple sclerosis and infections, there is strong evidence to suggest that the immune response contributes to genetic white matter disorders, epilepsy, neurodegenerative diseases, neuropsychiatric disorders, peripheral nervous system and neuro-oncological conditions, as well as aging. The COVID-19 pandemic also is a timely reminder of the importance of neuroinflammation in brain health given the shared pathobiology of COVID-19, acute stroke, and many other acquired neurological disorders.

We propose future perspectives including molecular biological studies and experimental models that may have the potential to push many areas of neuroimmunology. Such an understanding of neuroimmunology will open up new avenues for therapeutic approaches to manipulate neuroinflammation.

In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:

(1) The Neuroimmunology of Multiple Sclerosis;

(2) immune mechanisms (human nervous system and immune systems interact);

(3) clinical neuroimmunology research;

(4) neuroimmunological aspects of health and diseases;

(5) developments in the immunotherapy of neurological disorders.

I/We look forward to receiving your contributions.

You may choose our Joint Special Issue in Brain Sciences.

Dr. Maria Elsa Gambuzza
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• multiple sclerosis
• central nervous system
• inflammation
• neuroimmunology
• neuroinflammation